On Target Laboratories, Inc.
A near-infrared fluorescent imaging cocktail (OTL489) combining dual-targeted ligands conjugated to NIR dyes for real-time intraoperative visualization of lung tumor margins
Follows are private to you and power your alerts
Updated · ontargetlaboratories.com
- Sector
- Medtech
- Total capital
- $4M
- Federal grants
- $4M
- 5 awards · 2015–2018
- Rank in peer group#3 of 30
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 8 pending · first 2023
- Rank in peer group#6 of 30
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery$549K
- Federal grantHealth and Human S · Phase II · Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery$1.8M
- Federal grantHealth and Human S · Phase II · Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery$1.3M
- Federal grantHealth and Human S · Phase I · Tumor-specific fluorescent cocktail enables image-guided cytoreductive surgery.$218K
- Federal grantHealth and Human S · Phase I · Tumor-specific fluorescent cocktail enables image-guided cytoreductive surgery.$218K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 30 peers
Line = medianMedtech · Molecule
- Federal grants#3 · top 10%
- Granted patents#6 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 10- GrantedMethods Of Manufacture And Synthesis Of Fluorescent Dye Compounds And Uses ThereofUSPTOUS 12,673,940
- PendingSynthesis And Composition Of Photodynamic Therapeutic Agents For The Targeted Treatment Of CancerUSPTOApplication 18900771
- PendingFibroblast Activation Protein Targeted Dyes Their Related UsesUSPTOApplication 18660867
Show all 10 patent records
- Methods Of Manufacture And Synthesis Of Fluorescent Dye Compounds And Uses ThereofJul 7, 2026 · US 12,673,940Granted
- Synthesis And Composition Of Photodynamic Therapeutic Agents For The Targeted Treatment Of CancerAug 14, 2025 · Application 18900771Pending
- Fibroblast Activation Protein Targeted Dyes Their Related UsesNov 21, 2024 · Application 18660867Pending
- Psma-targeted Nir Dyes And Their UsesOct 24, 2024 · Application 18596815Pending
- Fibroblast Activation Protein Targeted Dyes Their Related UsesSep 12, 2024 · Application 18655248Pending
- Compositions Including Pafolacianine For The Identification Of Malignant LesionsAug 29, 2024 · Application 18631340Pending
- Ca Ix - Nir Dyes And Their UsesOct 12, 2023 · Application 18079297Pending
- Ca Ix - Nir Dyes And Their UsesJan 17, 2023 · US 11,555,821Granted
- Composition Including Pafolacianine For The Identification Of Malignant LesionsApplication PCTUS2023013479Pending
- Compositions Including Pafolacianine For The Identification Of Malignant LesionsApplication 19005415Pending
Related companies, and why
- Embody, Inc.Similar federal contract value in Medtech · null in contracts
- LISA HEALTH INC.Similar federal contract value in Medtech · null in contracts
- CONTROLPOINT INC.Similar federal contract value in Medtech · null in contracts
- Harbinger HealthSimilar federal contract value in Medtech · null in contracts
- WAVELY DIAGNOSTICS INCSimilar federal contract value in Medtech · null in contracts
- LARIAT BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .